Skip to main content


Fig. 2 | BMC Family Practice

Fig. 2

From: Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial

Fig. 2

Scheme of the risk assessments. Both versions of risk assessment leaflets contain general information on the following risk factors for ADR: HAS-BLED- and CHA2DS2-VASc-Score, drug-drug-interactions, age, renal function and pharmacogenetic factors. The individualized risk assessments additionally include a personalized evaluation of the patient’s personal data

Back to article page